6533b7d7fe1ef96bd12678f4

RESEARCH PRODUCT

From Regenerative Medicine to Endothelial Progenitor Cells as Potential Candidates

Carmela Rita Balistreri

subject

Endothelial stem cellCell therapymedicine.anatomical_structurebusiness.industryCellmedicineTranslational medicineBone marrowProgenitor cellbusinessNeuroscienceRegenerative medicine

description

A promising branch of translational medicine is Regenerative Medicine (RegMed). RegMed aims to improve health and quality of life by restoring, maintaining or enhancing tissues and functions of organs. In order to achieve this, RegMed utilizes several approaches. Among these, cell-based therapy represents the central focus of RegMed. Several cellular types have been considered for the investigation and application of regenerative cell therapy in disease organs. and bone marrow (BM)-derived endothelial progenitor cells (BM EPCs) are emerging as potential candidates. Here, particular emphasis is given to the description of their biological features, for understanding their relevance and potential in this field, as well as the related limitations in this and in successive chapters.

yearjournalcountryeditionlanguage
2017-01-01
https://doi.org/10.1007/978-3-319-55107-4_1